The distinction of benign from malignant lesions by frozen section (FS) can be difficult in patients with pulmonary, pancreatic, and other selected lesions in which the intraoperative diagnosis is important to help a surgeon decide whether to perform a major surgery. 1,2 Pathologists are generally trained to avoid making false-positive diagnoses of malignancy and tend to defer the diagnoses of difficult lesions. 3 This practice can help avoid unnecessary major procedures, but false-negative and deferred diagnoses also result in second surgeries, increasing morbidity and cost of care. 4, 5 Small peripheral pulmonary nodules, ground-glass opacities, and other small or ill-defined intrathoracic lesions are frequently difficult to diagnose by preoperative bronchoscopy or transthoracic biopsy. Patients with these lesions frequently receive their initial diagnosis at the time of intraoperative consultation and FS. A previous report from our laboratory has shown that the accuracy of the FS diagnosis of small lung lesions was excellent, with 100% specificity for a diagnosis of malignancy. 4 However, the study also showed a small number of false-negative errors and "deferrals," with sensitivities of 86.9% to 94.1% for pulmonary nodules smaller than 1.0 and 1.5 cm in diameter, respectively. 3 Most patients with malignant small pulmonary nodules that were not diagnosed correctly by FS had to undergo second video-assisted thoracotomies. A more recent study of 721 pulmonary FSs by Sirmali et al 5 demonstrated similar findings with 1 false-positive diagnosis (0.9%) and 7 false-negative diagnoses (3.3%).
The distinction of benign from malignant lesions by frozen section (FS) can be difficult in patients with pulmonary, pancreatic, and other selected lesions in which the intraoperative diagnosis is important to help a surgeon decide whether to perform a major surgery. 1, 2 Pathologists are generally trained to avoid making false-positive diagnoses of malignancy and tend to defer the diagnoses of difficult lesions. 3 This practice can help avoid unnecessary major procedures, but false-negative and deferred diagnoses also result in second surgeries, increasing morbidity and cost of care. 4, 5 Small peripheral pulmonary nodules, ground-glass opacities, and other small or ill-defined intrathoracic lesions are frequently difficult to diagnose by preoperative bronchoscopy or transthoracic biopsy. Patients with these lesions frequently receive their initial diagnosis at the time of intraoperative consultation and FS. A previous report from our laboratory has shown that the accuracy of the FS diagnosis of small lung lesions was excellent, with 100% specificity for a diagnosis of malignancy. 4 However, the study also showed a small number of false-negative errors and "deferrals," with sensitivities of 86.9% to 94.1% for pulmonary nodules smaller than 1.0 and 1.5 cm in diameter, respectively. 3 Most patients with malignant small pulmonary nodules that were not diagnosed correctly by FS had to undergo second video-assisted thoracotomies. A more recent study of 721 pulmonary FSs by Sirmali et al 5 demonstrated similar findings with 1 false-positive diagnosis (0.9%) and 7 false-negative diagnoses (3.3%).
In an attempt to reduce our current misdiagnosis and deferral rates, we reviewed our most recent 5-year experience with pulmonary FS using an evidence-based pathology (EBP) approach.
Upon completion of this activity you will be able to:
describe the histopathologic criteria that help distinguish bronchioloal-• veolar carcinoma from benign reactive atypia on lung frozen sections. review a model of evidence-based pathology for differential diagnosis of • lung lesions at frozen section. apply the comparative utility of posttest odds and likelihood ratios in • assessing morphologic features used in differential diagnosis.
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Questions appear on p 146. Exam is located at www.ascp.org/ajcpcme.
Materials and Methods
We followed an EBP approach that includes asking specific questions that could help solve a clinical problem, a systematic literature review querying for answers, appraisal of published best evidence, review of personal experience, integration of published and personal data with meta-analysis, if applicable, and data analysis using Bayesian statistics. 6, 7 
Asking Specific Questions
The following specific questions are important to learn how to improve FS diagnostic accuracy: (1) What diagnostic error rates (ERs) and deferral rates (DRs) can be used as a current standard of care for patients undergoing pulmonary FS? (2) Which are the specific pathologic features that help to distinguish reactive atypia (RA) from a bronchioloalveolar carcinoma or a well-differentiated adenocarcinoma (BAC-AC) on pulmonary FS? (3) What is the incidence of these pathologic features in RA and BAC-AC? (4) What is the diagnostic sensitivity and specificity of each pathologic feature? (5) Can one combine significant pathologic features into evidence-based diagnostic algorithms or rules for distinguishing RA from BAC-AC?
Querying the Literature for Answers
We looked for the answers to the 5 questions in several current textbooks of pulmonary pathology. We performed a systematic review of the English literature by using the MEDLINE database and the following search words: lung, pulmonary, frozen section, and intraoperative consultation.
Classification of Information Into Evidence Levels and Identification of Current Best Evidence
The articles identified during the literature search were classified into evidence levels. Level I evidence is provided by randomized controlled trials, level II evidence by prospective cohort studies, level III evidence by retrospective case-control studies, and level IV evidence by retrospective cases series, case reports, or other anecdotal data. 8, 9 
Review of Experience
The records of the Department of Pathology and Laboratory Medicine, Cedars Sinai Medical Center, Los Angeles, CA, were reviewed for the period of 2002 to 2007, after institutional review board approval, to identify consecutive patients who had undergone FS for the diagnosis of pulmonary nodules. In 143 patients from a total of 2,405 cases, the FS diagnosis was incorrect or had been deferred to the study of permanent sections. The ER and DR were calculated per patient, although, in most cases, a minimum of 2 to a maximum of 9 FSs had been performed to assess lymph nodes or margins of resection in addition to the primary lesion. Problems related to the distinction between RA and BAC-AC on FS were evaluated in detail, and the ERs and DRs for these differential diagnoses were calculated. Problems related to the FS diagnosis of lymphomas, neuroendocrine tumors, and other neoplasms will be the subject of future studies. All original FS slides were reviewed for the presence of 25 pathologic parameters that may be helpful to distinguish benign lesions from AC and classified by their visibility by the following:
1. Gross examination (n = 1): presence or absence of a distinct nodule or focal lesion 2. 40× microscopy (n = 10): central scar, peribronchiolar metaplasia, prominent inflammation, granulomas, growth patterns, and presence of necrosis. Prominent inflammation was defined when it involved at least 33% of the lesion. Growth patterns were classified into 5 pathologic features as lepidic, solid, papillary, glandular, and multiple. Presence of necrosis was scored when it involved at least 10% of the lesion.
3. 100× microscopy (n = 6): abrupt transition from normal alveolated lung parenchyma to an abnormal lesion, large cells, proportion of atypical cells within the lesion, and macronucleoli. Large cell size was defined when the cells and their nuclei were distinctly visible at this magnification. The proportion of atypical cells within the lesion was recorded as 3 pathologic features: 0% to 50%, 50% to 75%, and more than 75%. Macronucleoli were defined as those visible at this magnification.
4. 400× microscopy (n = 8): anisocytosis, nuclear/cytoplasmic ratio, nuclear stratification, nuclear overlap, irregular nuclear membrane, chromatin texture, nuclear pseudoinclusions, and atypical mitoses. Anisocytosis was noted when the size of atypical epithelial cells varied by 3 times or more the size of the neighboring epithelial cells. A nuclear/cytoplasmic ratio of more than 80 was noted as was nuclear stratification when it involved 3 or more nuclei. Chromatin texture was classified as normal, condensed or abnormal vesicular, or hyperchromatic.
Statistical Analysis
The presence or absence of the 25 diagnostic parameters in RA, BAC-AC, and AC were compared by using the χ 2 test using SPSS 11.0 for Windows (SPSS, Chicago, IL).
The sensitivity and specificity of each parameter were calculated for each of the 2 diagnoses. The presence of each parameter in RA and AC was evaluated by using the following Bayesian statistics: odds ratio (OR), risk ratio (RR), and likelihood ratio (LR).
Results
The pulmonary textbooks reviewed had no specific information to help answer our 5 questions and generally did not discuss in detail the problems associated with the FS diagnosis of pulmonary nodules. [10] [11] [12] [13] [14] Systematic review of the English literature revealed 300 level III or IV studies of pulmonary FS. However, only 3 studies analyzed the features essential for preventing misdiagnosis. 4 ,5, 15 Sienko et al, 15 in a review article by experienced lung pathologists, outlined and discussed in detail the pitfalls encountered with FS, especially as regards neoplastic vs reactive histologic patterns. Marchevsky et al 4 examined the sensitivity and specificity of pulmonary FSs but did not elaborate the various pathologic features that can aid in diagnosis. Sirmali et al 5 studied 721 patients in a surgical series, analyzed the sensitivity and specificity of FS, and provided opinions regarding problems in the interpretation of various histopathologic features. Multiple other studies of pulmonary FS discussed topics other than diagnostic pathologic features, such as the usefulness and importance of cytopathology, margins of resection, lymph node examination, immunohistochemical analysis, and newer molecular techniques. [16] [17] [18] [19] [20] [21] [22] The 100 erroneous FS diagnoses and deferrals of RA, AC, and BAC-AC at Cedars-Sinai Medical Center are listed by diagnostic category in zTable 1z. The DRs and ERs for all these diagnoses were 4.36% and 1.58%, respectively, and 2.7% and 1.5% for all diagnoses. DRs and ERs for the diagnoses of lymphoma and carcinoid tumor were considerably higher, at 10.38% and 18.18%, and will be the subject of a future study. Among the 25 pathologic features for the diagnosis of RA or BAC-AC, 11 were significant at a P value of less than .05 zTable 2z. Their incidence, sensitivity, and specificity were quite variable in RA and BAC-AC cases ( Organizing pneumonia (n = 14) 5 9 UIP (n = 9) 2 7 AAH (n = For example, proportion of atypia and macronucleoli are both highly significant pathologic features, but their sensitivities are very different at 0.81 and 0.12, respectively. Abrupt transition and macronucleoli are both highly significant pathologic features but their specificities for BAC-AC diagnoses are also very different, at 0.37 and 1.00, respectively. Bayesian statistics, shown in Table 3 , estimate more useful results, with some of the pathologic features resulting in high positive LR, RR, and/or OR values for the diagnosis of RA or BAC-AC zFigure 1z. For example, if a case shows the presence of macronucleoli (+LR = 999) and atypical mitoses (+LR = 9,999), the diagnosis of malignancy is almost certain; unfortunately, these features were noted in only 8.5% and 25.7% of cases, respectively. In contrast, if a case shows multiple patterns of growth (+LR = 3.77) and anisocytosis (+LR = 3.21), the diagnosis of malignancy is also likely but less certain than in the previous scenario. The features that may be useful in distinguishing RA from BAC-AC are illustrated in zImage 1z and zImage 2z. Some of the most common pitfalls and mimics are illustrated in zImage 3z, zImage 4z, and zImage 5z. LRs also allow for the stratification of significant pathologic features according to their diagnostic applicability for the diagnosis of RA and BAC-AC, as shown in Figure 1 . The results shown in Table 3 can be interpreted by using the semiarbitrary criteria proposed by Sackett et al 23 shown in zTable 4z.
Discussion
There is limited information in the literature regarding the ERs and DRs that could be used as a current standard of care of diagnostic accuracy for patients undergoing FS of pulmonary nodules. [24] [25] [26] [27] [28] [29] Three initial Q-Probes studies of pulmonary FS correlations conducted by the College of American Pathologists set the benchmark for a median error rate of 1.6% to 1.7% per FS diagnosis. 24 Our study shows similar results, with an ER of 1.58% per case. However, The photomicrograph has been enlarged to depict the mitoses. E, Macronucleoli. Nucleoli visible at low magnification were defined as macronucleoli (arrows). Although these were noted in only 8.5% of the cases, they were specific for a diagnosis of malignancy and, along with atypical mitoses, had the strongest positive likelihood ratio for the diagnosis of BAC-AC (H&E, ×100).
zImage 2z Presence of granulomatous inflammation (arrow) provides moderate evidence to exclude a diagnosis of malignancy. Accompanying nodular fibroblastic proliferation and reactive hyperplastic epithelial proliferation (arrowhead) is noted (H&E, ×100).
our ER by FS was probably considerably lower because many patients had undergone intraoperative examination of multiple specimens per procedure. The College of American Pathologists Q-Probes study did not query for DR, although deferrals can present thoracic surgeons with intraoperative therapeutic dilemmas.
There also is very limited information in the current pulmonary pathology literature regarding specific pathologic features that could help distinguish RA from BAC-AC on FS because the incidence, sensitivity, specificity, and clinical applicability of the various pathologic features suggested in textbooks or in the level III studies have not been formally evaluated. Our results suggest that the 5 most useful pathologic features for the diagnosis of AC are multiple growth patterns, anisocytosis, atypia of more than 75%, macronucleoli, and atypical mitoses. The presence of granulomatous pneumonia strongly suggests the diagnosis of RA. Our data also provide information about the sensitivity and specificity of these 6 features and highlight the fact that statistically significant features may have limited clinical applicability because of low or high frequency in particular A B C D zImage 3z Peribronchial metaplasia in a case of aspergillosis with reactive atypia simulating an adenocarcinoma. A, Dense, collagenous, central scarring with proliferation of metaplastic bronchiolar epithelium present on the surface of the scar along with moderate to severe inflammatory infiltrate is noted (H&E, ×40). B and C, At higher magnification, the glands appear infiltrative amid collagenous inflamed stroma that can be mistaken for a desmoplastic reaction (B and C, H&E, ×100). D, Tangential section through metaplastic bronchiolar epithelium and technical artifacts simulate the nuclear stratification, crowding, hyperchromasia, irregular nuclear membrane, and nuclear pseudoinclusions expected in a case of adenocarcinoma. Peribronchiolar metaplasia was noted in reactive and malignant cases with nearly equal frequency. This important pitfall can be avoided by adequate low-power examination of the lobular configuration of the metaplastic glands and by noting the presence of cilia (H&E, ×400).
conditions being considered in a differential diagnosis. [30] [31] [32] For example, macronucleoli were significant (P < .01) but were seen in only about 8% of BAC-AC cases. In contrast, abrupt transition between a lesion and relatively normal lung parenchyma was significant by χ 2 analysis (P = .016) but was seen in 62.5% and 88.46% of RA and AC cases, respectively. The variability of pathologic features in FS of RA and BAC-AC highlights the difficulty of developing simple evidence-based criteria for this differential diagnosis and the potential value of using an EBP approach and Bayesian statistics to identify diagnostic features and estimate their clinical applicability. 33 For example, the pathologic features abrupt transition and anisocytosis are significant by χ 2 analysis P values of less than .016 and less than .00,
respectively. However their diagnostic sensitivities and specificities are 0.88 and 0.37 and 0.56 and 0.83, respectively, limiting their applicability for the interpretation of a single FS. In contrast, and as shown in Table 3 , RR, OR, and, particularly, a positive LR calculation help stratify these and other pathologic features into clinically applicable criteria and to provide some information about the degree of C D zImage 4z Pitfalls in the diagnosis of adenocarcinoma. A, Alveolar macrophages and reactive type 2 pneumocytes in compressed alveolar spaces have an atypical appearance chiefly owing to their large size and pleomorphic nuclei (arrow). These may be difficult to distinguish from bronchioloalveolar carcinoma (H&E, ×100). B, Reactive epithelial atypia. The lesion is composed of atypical epithelial cells with prominent nuclei apparent at low magnification. The cells form a single layer and are of variable size and shape. The adjacent alveolar walls show fibroblastic proliferations (H&E, ×100). C, Alveoli lined by cells with moderate nuclear atypia in a case of nonmucinous bronchioloalveolar carcinoma. The atypical nuclei are present in an area devoid of inflammation and distributed in a more diffuse manner than usually seen in reactive atypia (H&E, ×400). D, Well-differentiated adenocarcinoma showing papillae lined by a single layer of cells with abundant cytoplasm. The usual nuclear features, such as altered nuclear/cytoplasmic ratio, anisonucleosis, nuclear stratification, and crowding, are minimal to absent in these cases (H&E, ×100).
diagnostic certainty. 34, 35 The RR probably provides the most intuitive results because it is interpretable and consistent with the way people think. The RR is calculated by dividing the probability of one event by the probability of another. 34, 35 For example, the RR of the feature grossly evident nodule is 7.75, indicating than one diagnosis is 7.75 times more likely than the other. However, it can provide misleading results because it does not account for the prevalence of the 2 competing diagnoses. The OR is calculated by the following equation: Odds = Moderate evidence for a diagnosis 2-5
Weak evidence for a diagnosis 0. No evidence for a diagnosis 0.2-0. 5 Weak evidence to exclude a diagnosis 0.1-0. 2 Moderate evidence to exclude a diagnosis <0. 1 Strong evidence to exclude a diagnosis * Adapted from Sackett et al. 23 A B C D zImage 5z Other mimics of adenocarcinoma on pulmonary frozen section. A, Organizing pneumonia at low power showing intraalveolar fibrosis and reactive pneumocytes (H&E, ×100). B, Higher power of the lesion shows focal florid type 2 pneumocyte hyperplasia with nuclear enlargement and occasional nucleoli, features that can lead to confusion with well-differentiated adenocarcinoma. The cells of malignant lesions usually show greater anisocytosis, and atypia is more in greater than 75% of the lesion. C, Reactive mesothelial cells simulating hyperplastic or malignant pneumocytes. The cells were focally present in the pleura and, owing to artifactual changes, simulated an intrapulmonary location (H&E, ×400). D, Sclerosing hemangioma with multiple growth patterns. The neoplastic cells usually lack anisocytosis and other atypical features and are present lining alveoli and within the stroma (H&E, ×100).
Probability/1 -Probability. It also is not adjusted for disease prevalence. 35, 36 We are not aware of widely used "scales" that compare various OR and RR results with the likelihood of a diagnosis, such as that proposed for LRs by Sackett et al. 23 The scale shown in Table 4 can provide some guidance regarding the degree of certainty that a pathologist can assign to the presence of a particular diagnostic feature. Pathologic features that yielded positive LR values ranging from 2 to 5 and classified by the schema of Sackett et al 23 as "weak evidence for a diagnosis" included multiple growth patterns, anisocytosis, and proportion of atypia. Features with positive LR values larger than 10 and classifiable according to the proposed schema as "strong evidence for a diagnosis" were macronucleoli and atypical mitoses. The latter were present in approximately 8.5% and 25% of AC cases, respectively, and should probably be searched for in difficult FS. The feature granuloma yielded a positive LR value of 0.13, classifiable as "moderate evidence to exclude a diagnosis."
Our study also suggests that information about nonsignificant pathologic features such as nuclear overlap, nuclear pseudoinclusions, and chromatin changes such as hyperchromasia and heterogeneous chromatin distribution can also be valuable clinically. These features are usually very useful for the diagnosis of BAC-AC on permanent sections, but pathologists should be aware that they are difficult to identify on FS and should not exclude a diagnosis of malignancy because of their absence.
Our study demonstrates the value of using a systematic EBP approach to the analysis of difficult diagnostic problems in pathology. In addition to identifying several clinically valuable pathologic features such as the presence of atypical mitoses, multiple growth patterns, degree of anisocytosis, proportion of atypia, macronucleoli, and granulomas for the distinction between RA and BAC-AC, our data highlight some of the potential shortcomings of descriptive statistics and the advantages of Bayesian statistics for the analysis of diagnostic problems in pathology.
